U.S. Markets close in 31 mins
S&P 500
3,338.75-10.41(-0.31%)Nasdaq
10,968.12-139.95(-1.26%)Russell 2000
1,559.43+14.80(+0.96%)
SPDR S&P Biotech ETF (XBI)
NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
113.58-0.23 (-0.20%)
As of 3:29PM EDT. Market open.
| Previous Close | 113.81 |
| Open | 113.54 |
| Bid | 113.35 x 1200 |
| Ask | 113.38 x 800 |
| Day's Range | 113.10 - 115.54 |
| 52 Week Range | 62.94 - 121.06 |
| Volume | 3,090,630 |
| Avg. Volume | 6,670,398 |
| Net Assets | 5.22B |
| NAV | 114.84 |
| PE Ratio (TTM) | N/A |
| Yield | 0.02% |
| YTD Daily Total Return | 20.62% |
| Beta (5Y Monthly) | 1.36 |
| Expense Ratio (net) | 0.35% |
| Inception Date | 2006-01-31 |
- GuruFocus.com
Biotech IPOs Capture Record $7.5 Billion in Second Quarter
The popularity of the sector continues with 57 new companies on tap to go public Continue reading...
- GuruFocus.com
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
- Barrons.com
Biotech Stocks Are Getting Ready to Run. How to Play It.
Given the amount of attention paid to Covid-19 treatments and vaccines, it would be easy to assume that all of the good news was already reflected in biotech stocks. That’s not quite the case.
© 2020 Verizon Media. All rights reserved.
